FDA lifts partial clinical hold on phase 3 low blood sugar treatment - biopharma-reporter.com

Retrieved on: 2024-09-12 19:04:22

Tags for this article:

Click the tags to see associated articles and topics

FDA lifts partial clinical hold on phase 3 low blood sugar treatment - biopharma-reporter.com. View article details on hiswai:

Excerpt

Rare disease biotech Rezolute recently announced that the FDA has lifted the partial clinical hold on RZ358 (ersodetug), a novel therapy in ...

Article found on: www.biopharma-reporter.com